BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28220199)

  • 1. [Novel pharmaceutical treatment approaches for gastric cancer].
    Lordick F
    Pathologe; 2017 Mar; 38(2):87-92. PubMed ID: 28220199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into next developments in advanced gastric cancer.
    Obermannová R; Lordick F
    Curr Opin Oncol; 2016 Jul; 28(4):367-75. PubMed ID: 27092990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapy for gastric cancer: Current status and future directions (Review).
    Yuan DD; Zhu ZX; Zhang X; Liu J
    Oncol Rep; 2016 Mar; 35(3):1245-54. PubMed ID: 26718131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and Future Therapies for Advanced Gastric Cancer.
    Davidson M; Okines AF; Starling N
    Clin Colorectal Cancer; 2015 Dec; 14(4):239-50. PubMed ID: 26524924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trastuzumab for gastric cancer.
    Meza-Junco J; Au HJ; Sawyer MB
    Expert Opin Biol Ther; 2009 Dec; 9(12):1543-51. PubMed ID: 19916733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapy in gastric cancer.
    Thiel A; Ristimäki A
    APMIS; 2015 May; 123(5):365-72. PubMed ID: 25706252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting HER 2 and angiogenesis in gastric cancer.
    Jomrich G; Schoppmann SF
    Expert Rev Anticancer Ther; 2016; 16(1):111-22. PubMed ID: 26567753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of tumour biology in the management of gastroesophageal cancer.
    Lordick F; Janjigian YY
    Nat Rev Clin Oncol; 2016 Jun; 13(6):348-60. PubMed ID: 26925958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-line chemotherapy for patients with advanced gastric cancer.
    Takahari D
    Gastric Cancer; 2017 May; 20(3):395-406. PubMed ID: 28260227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric cancer.
    Van Cutsem E; Sagaert X; Topal B; Haustermans K; Prenen H
    Lancet; 2016 Nov; 388(10060):2654-2664. PubMed ID: 27156933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Therapies in Advanced Gastric Cancer.
    Patel TH; Cecchini M
    Curr Treat Options Oncol; 2020 Jul; 21(9):70. PubMed ID: 32725377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Can Gastric Cancer Molecular Profiling Guide Future Therapies?
    Corso S; Giordano S
    Trends Mol Med; 2016 Jul; 22(7):534-544. PubMed ID: 27260398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer.
    Roviello G; Ravelli A; Polom K; Petrioli R; Marano L; Marrelli D; Roviello F; Generali D
    Cancer Lett; 2016 Mar; 372(2):187-91. PubMed ID: 26797419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in targeted therapy for gastric cancer based on tumor driver genes.
    Wu S; Xu P; Zhang F
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 53(1):73-83. PubMed ID: 38413217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New agents on the horizon in gastric cancer.
    Lordick F; Shitara K; Janjigian YY
    Ann Oncol; 2017 Aug; 28(8):1767-1775. PubMed ID: 28184417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis inhibitors in early development for gastric cancer.
    Pinto MP; Owen GI; Retamal I; Garrido M
    Expert Opin Investig Drugs; 2017 Sep; 26(9):1007-1017. PubMed ID: 28770623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New advances in targeted gastric cancer treatment.
    Lazăr DC; Tăban S; Cornianu M; Faur A; Goldiş A
    World J Gastroenterol; 2016 Aug; 22(30):6776-99. PubMed ID: 27570417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ramucirumab and its use in gastric cancer treatment.
    Bronte G; Galvano A; Cicero G; Passiglia F; Rolfo C; Bazan V; Russo A
    Drugs Today (Barc); 2014 Sep; 50(9):613-21. PubMed ID: 25313368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramucirumab for gastric cancer.
    Shitara K; Ohtsu A
    Expert Rev Gastroenterol Hepatol; 2015 Feb; 9(2):133-9. PubMed ID: 25431958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ramucirumab for the treatment of gastric cancers, colorectal adenocarcinomas, and other gastrointestinal malignancies.
    Aprile G; Ferrari L; Cremolini C; Bergamo F; Fontanella C; Battaglin F; Rihawi K; Lonardi S; Loupakis F; Scartozzi M
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):877-85. PubMed ID: 27149032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.